1. Sirtuins at the Service of Healthy Longevity
   Mateusz Watroba et al, 2021, Frontiers in Physiology CrossRef
2. Obesity aggravated hippocampal-dependent cognitive impairment after sleeve gastrectomy in C57/BL6J mice via SIRT1/CREB/BDNF pathway
   Yuanyuan Ma et al, 2022, Experimental Brain Research CrossRef
3. Does CETP rs5882, rs708272, SIRT1 rs12778366, FGFR2 rs2981582, STAT3 rs744166, VEGFA rs833068, IL6 rs1800795 polymorphisms play a role in optic neuritis development?
   Greta Gedvilaite et al, 2019, Ophthalmic Genetics CrossRef
4. Common Pathogenetic Pathways of Non-Alcoholic Fatty Liver Disease and Type 2 Diabetes Mellitus
   Charalampos K. Giannopoulos et al, 2023, Current Diabetes Reviews CrossRef
5. The sirtuin 1 activator SRT1720 alleviated endotoxin-induced fulminant hepatitis in mice
   Dan Zhou et al, 2021, Experimental Animals CrossRef
6. EX-527 Prevents the Progression of High-Fat Diet-Induced Hepatic Steatosis and Fibrosis by Upregulating SIRT4 in Zucker Rats
   Amit Kundu et al, 2020, Cells CrossRef
7. Sirtuins-Mediated System-Level Regulation of Mammalian Tissues at the Interface between Metabolism and Cell Cycle: A Systematic Review
   Parcival Maissan et al, 2021, Biology CrossRef
8. Role of acetylation in nonalcoholic fatty liver disease: a focus on SIRT1 and SIRT3
   Fatiha Nassir, 2020, Exploration of Medicine CrossRef
9. Fatty Liver Disease and Utility of Stem Cells in Developing the Disease Model
   Shanti Choudhary et al, 2021, Stem Cells in Veterinary Science CrossRef
10. The role of sirtuin1 in liver injury: molecular mechanisms and novel therapeutic target
    Mufei Wang et al, 2024, PeerJ CrossRef
11. (The CD36 receptor - the link between inflammation, lipid metabolism, and cardiovascular disease)
    Rudolf Poledne et al, 2024, Cor et Vasa CrossRef
12. Phytotherapy as Multi-Hit Therapy to Confront the Multiple Pathophysiology in Non-Alcoholic Fatty Liver Disease: A Systematic Review of Experimental Interventions
    Ayokanmi Ore et al, 2021, Medicina CrossRef